Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

I also believe that Doctors Without Borders don't need any FDA /...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 18 Last

Share
Profile

Follow
newt9905

121 Posts.

4

06/09/18

17:42

Post #: 35452611
Share

Originally posted by MyBentley ↑

Thanks Red bar,

BL stated to me in an email before the current release of the excellent Breath Easy blind trial data, that the RAP team are using all the data including the rejected data and failed data from last year to fine tune the Resapp Algorithm.

It is my belief that this will be happening as I write this.
I believe the RAP team will be doing further fine tuning including the less than 3% rejected data and the already released excellent Australian data, before the US pediatric data is tested.

It is because of this that my belief in the above is that the US blind trial data will exceed the Australian Breath Easy data results.

I believe that once the US data is released, "Doctors without Borders" will come on board very soon after and paying a nominal License fee for unlimited use in the third world, thus eliminating the need for any CR.

All the above are my opinions and beliefs.

MB

Expand

I also believe that Doctors Without Borders don't need any FDA / CE Mark / TGA approvals to implement the app in the field too if memory serves me correctly?

RAP Price at posting: 23.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

There are more pages in this discussion • 11 more messages in this thread...

First 18 Last

Add RAP (ASX) to my watchlist